Improved HIV-1 incidence estimates using the BED capture enzyme immunoassay

AIDS

Volumn 22, Issue 4, 2008, Pages 511-518

  Hargrove, John W ^a,f   Humphrey, Jean H ^a,c,g   Mutasa, Kuda ^a   Parekh, Bharat S ^d   McDougal, J Steve ^d   Ntozini, Robert ^a   Chidawanyika, Henry ^a   Moulton, Lawrence H ^c   Ward, Brian ^e   Nathoo, Kusum ^b   Iliff, Peter J ^a   Kopp, Ekkehard ^f  

^a ZVITAMBO Project   (Zimbabwe)

^b UNIVERSITY OF ZIMBABWE   (Zimbabwe)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e MONTREAL GENERAL HOSPITAL   (Canada)

^f STELLENBOSCH UNIVERSITY   (South Africa)

^g ZVITAMBO   (Zimbabwe)

Author keywords

BED; HIV 1; Incidence

Indexed keywords

ARTICLE; CONTROLLED STUDY; FEMALE; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; INCIDENCE; MAJOR CLINICAL STUDY; MATERNAL AGE; PRIORITY JOURNAL; PUERPERIUM; SEROCONVERSION;

AIDS SERODIAGNOSIS; EPIDEMIOLOGIC METHODS; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOGLOBULIN G; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; ZIMBABWE;

EID: 39849103123     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3282f2a960     Document Type: Article

References (16)

1. McDougal JS, Pilcher CD, Parekh BS, Gershy-Damet G, Branson BM, Marsh K, Wiktor SZ. Surveillance for HIV-1 incidence using tests for recent infection in resource-constrained countries. AIDS 2005; 19:S25-S30.
2. Parekh BS, Kennedy MS, Dobbs T, Pau C-P, Byers R, Green T, et al. Quantitative detection of increasing HIV type 1 antibodies after seroconversion: a simple assay for detecting recent HIV infection and estimating incidence. AIDS Res Hum Retroviruses 2002; 18:295-307.
3. Parekh BS, McDougal JS. New approaches for detecting recent HIV-1 infection. AIDS Rev 2001; 3:183-193.
4. Nesheim S, Parekh B, Sullivan K, Bulterys M, Dobbs T, Lindsay M, et al. Temporal trends in HIV-1 incidence among inner-city childbearing women in Atlanta: use of the IgG-Capture BED-Enzyme Immunoassay. AIDS Res Hum Retroviruses 2005; 21:537-544.
5. CDC. Using the BED HIV-1 Capture EIA Assay to Estimate Incidence Using STARHS in the Context of Surveillance in the US. Centers for Disease Control and Prevention, Division of HIV/ AIDS Prevention. Atlanta, Georgia [CDC] updated October 2007. http://www.cdc.gov/hiv/topics/surveillance/resources/ factsheets/BED.htm.
6. UNAIDS Reference Group for Estimates, Modelling and Projections. Statement on the use of the BED-assay for the estimation of HIV-1 incidence for surveillance or epidemic monitoring. Report of a meeting of the UNAIDS Reference Group for Estimates, Modelling and Projections. Athens, Greece, December 13th-15th 2005. Geneva: UNAIDS; 2005. http://www.epidem.org/ Publications/BED%20statement.pdf.
7. Iliff PJ, Piwoz EG, Tavengwa NV, Zunguza CD, Marinda ET, Nathoo KJ, et al. Early exclusive breastfeeding reduces the risk of postnatal HIV-1 transmission and increases HIV-free survival. AIDS 2005; 19:699-708.
8. Humphrey JH, Iliff PJ, Marinda E, Mutasa K, Moulton LH, Nathoo KJ, et al. Effects of a single large dose of vitamin A, given during the postpartum period to HIV-positive women and their infants, on child HIV infection, HIV-free survival, and mortality. J Infect Dis 2006; 193:860-871.
9. Humphrey JH, Hargrove JW, Malaba LC, Iliff PJ, Moulton LH, Mutasa K, et al. HIV incidence among postpartum women in Zimbabwe: risk factors and the effect of vitamin A supplementation. AIDS 2006; 20:1437-1446.
10. Zvandasara P, Hargrove JW, Ntozini R, Chidawanyika H, Iliff PJ, Moulton LH, et al. Mortality and morbidity among postpartum HIV-positive and HIV-negative women in Zimbabwe: risk factors, causes, and impact of single-dose postpartum vitamin A supplementation. JAIDS 2006; 43:107-116.
11. McDougal JS, Parekh BS, Peterson ML, Branson BM, Dobbs T, Ackers M, et al. Comparison of HIV-1 incidence observed during longitudinal follow-up with incidence estimated by cross-sectional analysis using the BED capture enzyme immunoassay. AIDS Res Hum Retroviruses 2006; 22:945-952.
12. Karita E, Price M, Hunter E, Chomba E, Allen S, Fei L, et al. Investigating the utility of the HIV-1 BED capture enzyme immunoassay using cross-sectional and longitudinal seroconverter specimens from Africa. AIDS 2007; 21:403-408.
13. Sakarovitch C, Rouet F, Murphy G, Minga AK, Alioum A, Dabsi F, et al. Do tests devised to detect recent HIV-1 infection provide reliable estimates of incidence in Africa? JAIDS 2007; 45:107-116.
14. Kim A, McDougal S, Hargrove J, Morgan M, Nolan M, Marum L, Abdullahi A, Humphrey J, Mutasa K, Parekh B. Towards more plausible estimates of HIV incidence in cross-sectional serologic surveys- in Africa? Application of a HIV-1 incidence assay with post-assay adjustment. Fourteenth Conference on Retroviruses and Opportunistic Infections. Los Angeles, February 2007 [abstract V-190].
15. Rehle T, Shisana O, Pillay V, Zuma K, Puren A, Parker W. National HIV incidence measures: new insights into the South African epidemic. S Afr Med J 2007; 97:194-199.
16. Gray HR, Li X, Kigozi G, Serwadda D, Brahmbhatt H, Wabwire-Mangen F, et al. Increased risk of incident HIV during pregnancy in Rakai, Uganda: a prospective study. Lancet 2005; 366:1182-1188.